ORLANDI, Martina
 Distribuzione geografica
Continente #
NA - Nord America 4.970
AS - Asia 4.823
EU - Europa 1.459
SA - Sud America 591
Continente sconosciuto - Info sul continente non disponibili 103
AF - Africa 96
OC - Oceania 6
Totale 12.048
Nazione #
US - Stati Uniti d'America 4.750
CN - Cina 1.691
SG - Singapore 1.383
IT - Italia 606
VN - Vietnam 447
BR - Brasile 439
HK - Hong Kong 417
KR - Corea 292
BD - Bangladesh 236
GB - Regno Unito 226
RU - Federazione Russa 126
CA - Canada 96
IN - India 95
FI - Finlandia 93
FR - Francia 91
DE - Germania 79
NL - Olanda 56
AR - Argentina 54
ID - Indonesia 51
MX - Messico 43
LT - Lituania 33
EC - Ecuador 30
IQ - Iraq 26
JP - Giappone 23
ZA - Sudafrica 23
PK - Pakistan 22
SE - Svezia 20
AE - Emirati Arabi Uniti 19
PL - Polonia 19
TR - Turchia 19
VE - Venezuela 19
AT - Austria 17
CO - Colombia 17
ES - Italia 17
SV - El Salvador 16
PY - Paraguay 15
CR - Costa Rica 14
EG - Egitto 14
MA - Marocco 14
UA - Ucraina 14
TN - Tunisia 12
PH - Filippine 10
SA - Arabia Saudita 10
UZ - Uzbekistan 10
BE - Belgio 9
TT - Trinidad e Tobago 9
HN - Honduras 8
IL - Israele 8
GT - Guatemala 7
JO - Giordania 7
CL - Cile 6
DZ - Algeria 6
EE - Estonia 6
KZ - Kazakistan 6
NI - Nicaragua 6
NP - Nepal 6
RO - Romania 6
AZ - Azerbaigian 5
DK - Danimarca 5
GR - Grecia 5
KE - Kenya 5
MY - Malesia 5
SC - Seychelles 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
AU - Australia 4
BB - Barbados 4
CW - ???statistics.table.value.countryCode.CW??? 4
CZ - Repubblica Ceca 4
GE - Georgia 4
JM - Giamaica 4
KG - Kirghizistan 4
PA - Panama 4
PE - Perù 4
TH - Thailandia 4
AL - Albania 3
BY - Bielorussia 3
ET - Etiopia 3
IE - Irlanda 3
KW - Kuwait 3
NG - Nigeria 3
PS - Palestinian Territory 3
PT - Portogallo 3
TW - Taiwan 3
AO - Angola 2
BG - Bulgaria 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
MD - Moldavia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
UG - Uganda 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
Totale 11.927
Città #
Hefei 1.021
Santa Clara 905
Ashburn 814
Singapore 763
San Jose 540
Council Bluffs 415
Hong Kong 411
Seoul 290
Ho Chi Minh City 168
London 160
Los Angeles 118
Beijing 108
New York 106
Hanoi 105
The Dalles 91
Chicago 71
Milan 70
Buffalo 67
Lauterbourg 66
Helsinki 61
Kent 59
Dallas 53
São Paulo 48
Boardman 44
Rome 42
Florence 33
Jakarta 32
Orem 32
Bologna 31
Moscow 30
Munich 27
Salt Lake City 26
Brooklyn 24
Phoenix 24
Montreal 23
Amsterdam 22
Haiphong 22
Lappeenranta 22
Ovada 22
Da Nang 21
Naples 21
Shanghai 20
Chennai 18
Atlanta 17
Guangzhou 17
Turin 17
Warsaw 17
Columbus 16
North Bergen 16
Parma 16
Charlotte 15
Mexico City 14
Modena 14
Nuremberg 14
Philadelphia 14
Reggio Emilia 14
San Francisco 14
Toronto 14
Baghdad 13
Denver 13
Houston 13
Quito 13
Rio de Janeiro 12
San Salvador 12
Schiffdorf 12
Brasília 11
Dubai 11
Hillsboro 11
Johannesburg 11
Lansdowne 11
Tampa 11
Tokyo 11
Elk Grove Village 10
Lancaster 10
Manchester 10
Trieste 10
Turku 10
Boston 9
Detroit 9
Mumbai 9
Newark 9
Poplar 9
Biên Hòa 8
Guarulhos 8
Indianapolis 8
Louisville 8
Saint Augustine 8
San José 8
Sterling 8
Tashkent 8
Venice 8
Amman 7
Asunción 7
Bari 7
Belo Horizonte 7
Campinas 7
Cleveland 7
Formigine 7
Frankfurt am Main 7
Guiyang 7
Totale 7.670
Nome #
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension 221
MENSTRUATION-RELATED DISORDERS IN WOMAN WITH RHEUMATIC DISEASE (RDS): BLEEDING AND PAIN 216
Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study 216
ORAL MANIFESTATIONS IN SYSTEMICSCLEROSIS: CLINICAL EVALUATION OF APERSONAL CASE SERIES OF 13 SCLERODERMAPATIENTS 212
Ultrashort Echo-Time Magnetic Resonance Imaging Sequence in the Assessment of Systemic Sclerosis-Interstitial Lung Disease 205
Role of COVID-19 in the progression of scleroderma interstitial lung disease and new onset pulmonary hypertension: a challenging case report. 202
A New Promising Role for Selexipag in the Treatment of Scleroderma Vasculopathy: Preliminary Results From a Third Level Italian Scleroderma Center 193
VULVAR HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL CHANGES IN PATIENTS WITH PRIMARY SJÖGREN SYNDROME 191
THE PREDICTIVE ROLE OF THE TAPSE/sPAP RATIO FOR CARDIOVASCULAR EVENTS AND MORTALITY IN SYSTEMIC SCLEROSIS COMPLICATED BY PULMONARY HYPERTENSION 186
Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review 186
ENDOMETRIOSI E MALATTIE REUMATICHE: LA PUNTA DELL’ICEBERG DEI NUMEROSI DISTURBI MESTRUALI IN CORSO DI MALATTIA REUMATICA 184
Mindfulness Program in Sjögren's Syndrome and Non-Sjögren's Sicca Syndrome Patients: A Pilot Study on Quality of Life and Psychological Distress 179
A manual therapy intervention improves symptoms in patients with carpal tunnel syndrome: a pilot study 178
Computed Tomography Predictors of Mortality or Disease Progression in Systemic Sclerosis–Interstitial Lung Disease: A Systematic Review 177
Secondary cryofbrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study 176
Secondary cryofibrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study. 172
A three-dimensional measurement method on MR arthrography of the hip to classify femoro-acetabular impingement 171
Chest radiography findings of COVID-19 pneumonia: a specific pattern for a confident differential diagnosis 166
Towards a comprehensive approach to the management and prognosis of systemic sclerosis's patients: The role of comorbidities in the SPRING-SIR registry 163
The Role of Bronchoalveolar Lavage in Systemic Sclerosis Interstitial Lung Disease: A Systematic Literature Review 163
Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sjӧgren's syndrome: A systematic review from the Italian Society of Rheumatology 162
Gynaecological symptoms and sexual disability in women with primary Sjögren's syndrome and sicca syndrome 157
The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review 156
Long-term effects of selexipag in systemic sclerosis-associated digital ulcers: a case control multicentre observational study 155
Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screening 154
How radiology can help pulmonary tuberculosis diagnosis: analysis of 49 patients 153
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 152
Potential Role of JAK Inhibitors in the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Narrative Review from Pathogenesis to Real-Life Data 151
THE FIRST 1000 DAYS OF LIFE AND REPRODUCTIVE DISORDERS IN WOMAN WITH RHEUMATIC DISEASE (RDS) 150
Sjögren's syndrome: one year in review 2023 150
Women with primary sjögren syndrome and with Non-Sjögren Sicca syndrome show similar vulvar histopathologic and immunohistochemical changes 149
BMP-4 and fetuin A in systemic sclerosis patients with or without calcinosis 149
MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRY 148
L’IPERTENSIONE POLMONARE: DALLE NUOVE LINEE GUIDA ALLA PRATICA CLINICA 147
Clinical and histological features of patients with primary Sjӧgren’s syndrome and autoimmune thyroiditis: a national multicentre cross-sectional study 146
Doubts and concerns about COVID-19 uncertainties on imaging data, clinical score, and outcomes 144
Radiological patterns and pulmonary function values of lung involvement in primary Sjögren’s syndrome: A pilot analysis 144
CT evaluation of interstitial lung disease related to systemic sclerosis: visual versus automated assessment. A systematic review 142
Lung Ultrasound B-Lines in the Evaluation of the Extent of Interstitial Lung Disease in Systemic Sclerosis 142
Feasibility, face, and content validity of quantitative computed tomography in interstitial lung disease related to connective tissue diseases 140
Artificial Intelligence and Radiomics at the University of Florence 136
Doppler ultrasound unveils splanchnic arteries ischemia allowing early successful revascularization in symptomatic systemic sclerosis patients 133
Morphological, Functional and Texture Analysis Magnetic Resonance Imaging Features in the Assessment of Radiotherapy-Induced Xerostomia in Oropharyngeal Cancer 133
Advanced and traditional chest MRI sequence for the clinical assessment of systemic sclerosis related interstitial lung disease, compared to CT: disease extent analysis and correlations with pulmonary function tests 131
Ischemia–hyperpnea test is useful to detect patients with Fibromyalgia syndrome 130
Menstruation-Related Disorders-Dysmenorrhea and Heavy Bleeding-as Significant Epiphenomena in Women With Rheumatic Diseases 130
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry. 127
Systemic sclerosis: one year in review 2022 127
One year in review 2015: spondyloarthritis 125
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life 123
Sjögren's syndrome: state of the art on clinical practice guidelines 122
The Role of Imaging in COVID-19 Pneumonia Diagnosis and Management: Main Positions of the Experts, Key Imaging Features and Open Answers 122
Techniques, Tricks, and Stratagems of Oral Cavity Computed Tomography and Magnetic Resonance Imaging 121
Myositis-Specific and Myositis-Associated Antibodies in Fibromyalgia Patients: A Prospective Study 121
Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for Rheumatology 121
“Usual” interstitial pneumonia with autoimmune features: a prospective study on a cohort of idiopathic pulmonary fibrosis patients 118
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? 117
First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING-SIR registry 117
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis—Interstitial Lung Disease in the European Scleroderma Trial and Research Database 114
The importance of body image and aesthetic medicine in systemic sclerosis 112
Sintomi Ginecologici E Disabilità Sessuale In Donne Con Sindrome Di Sjögren Primaria E Sindrome Sicca 111
One year in review 2019: Sjögren’s syndrome 111
Patients with interstitial lung disease secondary to autoimmune diseases: How to recognize them? 110
Prevalence of sacroiliitis on magnetic resonance enterography in Crohn's disease and its association with intestinal findings: a monocentric observational cross-sectional study 109
Elderly-onset systemic sclerosis defines a distinct clinical subset: analysis from the SPRING registry of the Italian Society for Rheumatology 108
Ultrasound evaluation of bowel vasculopathy in systemic sclerosis 108
One year in review 2017: primary Sjögren's syndrome 107
The emerging challenge of pain in systemic sclerosis: Similarity to the pain experience reported by Sjogren's syndrome patients 104
The COVID-19 pandemic highlights the need for a psychological support in systemic sclerosis patients 104
One year in review 2018: Systemic sclerosis 103
Quantitative chest tomography indexes are related to disease activity in systemic sclerosis: results from a cross-sectional study 102
One year in review 2019: Systemic sclerosis 101
The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review 101
Infection or autoimmunity? The clinical challenge of interstitial lung disease in systemic sclerosis during the COVID-19 pandemic 99
One year in review 2021: systemic sclerosis 99
Mindfulness Meditation: An Interesting Opportunity for the Rheumatologist 96
The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress 90
The clinical profile of systemic sclerosis without a ‘scleroderma pattern’ at nailfold capillaroscopy: results from the multicenter SPRING registry of the Italian Society of Rheumatology 89
One year in review 2020: Systemic sclerosis 88
One year in review 2016: idiopathic inflammatory myopathies 84
One year in review 2017: Systemic sclerosis 81
Pulmonary magnetic resonance imaging in systemic sclerosis: a jump in the future to unravel inflammation in interstitial lung disease 77
Gastrointestinal involvement in very early and established systemic sclerosis: insights from the SPRING-SIR national Italian registry. 72
Beyond systemic lupus erythematosus: a systematic review on the use of belimumab in other connective tissue diseases and vasculitides 72
Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry 72
Comment on: Long-term effects of selexipag in SSc-associated digital ulcers: a case-control multicentre observational study: reply 71
Optical coherence tomography angiography: a window on systemic sclerosis microangiopathy 68
Risk of malignancy and biologic therapy in rheumatic inflammatory diseases: A single-center experience 67
Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR) 66
Age and onset timing of Raynaud’s phenomenon and first non-Raynaud symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the Italian national multicenter Systemic Sclerosis Progression INvestiGation registry of the Italian Society for Rheumatology (SPRING-SIR) 58
Exploring Disease-Specific Risk Factors for Vertebral Fractures in Systemic Sclerosis: Insights from the ScleroRER Study Group 41
Clinical and serological features of triple autoantibody-­ negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology 37
Respiratory care approach during acute exacerbation of rheumatic disease-associated interstitial lung disease 8
Impact of Severe COVID‐19 on Interstitial Lung Disease in Autoimmune Systemic Diseases 6
Totale 12.048
Categoria #
all - tutte 47.348
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.348


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024259 0 0 37 48 38 19 10 18 9 10 30 40
2024/20253.056 68 11 17 178 628 407 127 206 339 211 466 398
2025/20266.701 630 521 743 767 598 317 765 331 557 584 554 334
2026/20272.032 296 441 466 829 0 0 0 0 0 0 0 0
Totale 12.048